Business NewsPR NewsWire • Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan

Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan

Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan

TOKYO, November 7, 2012 /PRNewswire/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) confirms the information released today by Novartis Pharma K.K. that it has submitted an application for the registration of QVA149, an investigational fixed dose combination of two...

View More : http://www.prnewswire.com/news-releases/sosei-group-corporation-qva149-filed-by-licensing-partner-as-a-once-daily-mainte...
Releted News by prnewswire
Early Results Demonstrate Electoral Clout Of Latino Voters In 2012
Objet Showcases Latest 3D Printing Innovations at EuroMold 2012
Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
Pyxis Capital Launches Pyxis iBoxx Senior Loan ETF
Fire Island Pines Recovering from Hurricane Sandy